Entero Therapeutics Inc. (ENTO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Entero Therapeutics Inc.

NASDAQ: ENTO · Real-Time Price · USD
3.11
0.81 (35.22%)
At close: Sep 12, 2025, 3:13 PM

Entero Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a 35.6K 12.29K 7.32K 23.41K 23.13K 22.85K 22.57K 22.29K 30.82K 30.5K 132.35K 138K n/a n/a
Gross Profit
n/a n/a n/a n/a -35.6K -12.29K -7.32K -23.41K -23.13K -22.85K -22.57K -22.29K -30.82K -30.5K -132.35K -138K n/a n/a
Operating Income
-638.86K -821.39K -1.2M -1.89M -3.43M -9.23M -4.09M -3.43M -4.18M -4.06M -2.28K 4.39K -5.41K -9.38K -8.81K -30.4K -9.28K -8.21K
Interest Income
n/a n/a n/a n/a 218.00 228.00 224.00 229.00 205.00 1.87K 4.69K 2.66K 926.00 139.00 1.17K 0.74 2.95 403.00
Pretax Income
-674.93K -948.11K -1.19M -1.9M -3.43M -9.29M -4.1M -3.43M -4.19M -4.07M -3.99K 4.39K -5.41K -9.63K -11.17K -30.4K -9.28K -7.69K
Net Income
-998.27K -1.26M -12.24M -2.58M -8.81M 5.57M -4.1M -3.43M -4.19M -4.07M -3.99M 4.39M -5.41M -9.63M -11.17M -30.4M -9.28M -7.69M
Selling & General & Admin
628.23K 805.56K 1.18M 1.69M 3.17M 8.66M 2.79M 2.42M 2.83M 2.7M 2.18K 2.9K 2.5K 4.41K 3.04K 6.02K 3.63K 5.7K
Research & Development
10.63K 15.83K 21.42K 207K 219.59K 565.96K 1.31M 1.01M 1.35M 1.36M 101.82 7.29K 2.91K 4.98K 5.78K 24.38K 5.65K 2.52K
Other Expenses
n/a n/a n/a n/a n/a -653 -495 n/a -2.62K -1.11K 6.56K n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
638.86K 821.39K 1.2M 1.89M 3.39M 9.23M 4.09M 3.43M 4.18M 4.06M 3.98K 4.39K 5.41K 9.62K 11.17K 30.4K 9.28K 7.68K
Interest Expense
36.07K 17.9K n/a n/a n/a 66.2K 7.05K 1.25K 5.18K 8.99K 6.19K 863.00 3.22K 5.61K 2.4K 742.00 2.95K 5.14K
Selling & Marketing Expenses
n/a n/a n/a n/a -35.6K n/a n/a n/a n/a n/a -115 36.00 50.00 28.00 -186 79.00 57.00 52.00
Cost & Expenses
638.86K 821.39K 1.2M 1.89M 3.43M 9.23M 4.09M 3.43M 4.18M 4.06M 3.98K 4.39K 5.41K 9.62K 11.17K 30.4K 9.28K 7.68K
Income Tax Expense
n/a n/a 10.6M n/a 4.26M -14.86M n/a n/a n/a n/a -1.7M 157.58 144.43 685.79 116.23 118.09 3.45K 22.3K
Shares Outstanding (Basic)
4.77M 4.77M 4.75M 4.55M 2.29M 1.76M 357.32K 378.3K 113.55K 114.03K 49.75K 11.44K 5.19K 3.7K 3.54K 2.22K 1.86K 1.32K
Shares Outstanding (Diluted)
4.77M 4.77M 4.75M 4.55M 2.29M 1.32M 357.32K 378.3K 113.55K 114.03K 49.75K 11.61K 5.19K 3.7K 3.54K 2.22K 1.86K 1.32K
EPS (Basic)
-0.21 -0.28 -2.57 -0.57 -3.84 3.12 -11.48 -9.08 -36.89 -35.7 -80.12 370.12 -1.04K -2.6K -3.16K -13.67K -4.99K -5.83K
EPS (Diluted)
-0.21 -0.28 -2.57 -0.57 -3.84 4.23 -11.48 -9.08 -36.89 -35.7 -80.12 364.59 -1.04K -2.6K -3.16K -13.67K -4.99K -5.83K
EBITDA
-638.86K -930.2K -1.2M -1.89M -3.39M -9.21M -4.09M -3.43M -4.17M -4.06M -3.96M 4.41M -5.4M -9.59M -11.04M -30.26M -9.14M -7.55M
EBIT
-638.86K -930.2K -1.2M -1.89M -3.43M -9.23M -4.09M -3.43M -4.18M -4.06M -3.98M 4.39M -5.4M -9.62M -11.17M -30.4M -9.28M -7.68M
Depreciation & Amortization
n/a n/a n/a 1.34K 35.32K 12.29K 7.32K 7.32K 7.32K 7.32K 7.32 7.32 7.32 7.32 137.20 138.26 133.88 132.91